-
Group
BackGroupView
-
Who we are
BackWho we areView
- Profile
- Key figures
-
Governance
BackGovernanceView
-
Governance
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Our history
-
Who we are
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
What we do
BackWhat we doView
- At a glance
- Large Industries
- Industrial Merchant
- Healthcare
- Electronics
- Engineering & Construction
- Global Markets & Technologies
-
What we do
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Our strategy
BackOur strategyView
-
Our strategy
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Innovation
BackInnovationView
-
Research & Development
BackResearch & DevelopmentView
-
Research & Development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Digital transformation
-
Global markets & Technologies
BackGlobal markets & TechnologiesView
-
Global markets & Technologies
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Air Liquide Venture Capital
-
Innovation
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Research & Development
-
Sustainable development
BackSustainable developmentView
- Safety
-
Ethics
BackEthicsView
-
Ethics
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Human rights
- Climate objectives
- Environmental data
- Vigilance plan
- Extra-financial ratings
-
Stakeholders
BackStakeholdersView
-
Stakeholders
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Sustainable development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Where we operate
- Group publications
-
Group
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Who we are
-
Businesses
BackBusinessesView
-
Industry
BackIndustryView
-
Industry
-
Healthcare
BackHealthcareView
- Presentation
-
Our expertise
-
Our R&D
- Diseases
-
Public health challenges
BackPublic health challengesView
- Aging population
- Rise in chronic diseases
- Urbanization and lifestyle changes
- Reinventing the hospital
-
Public health challenges
-
Healthcare
-
Electronics
-
Engineering & Construction
BackEngineering & ConstructionView
-
Engineering & Construction
-
Science & New energies
BackScience & New energiesView
-
Science & New energies
-
Businesses
-
Industry
-
Magazine
BackMagazineView
- Industry of the future
- Healthcare
- Energy transition
- Customer experience
- Digitization
- Open innovation
- Science
-
Magazine
- Customers
-
Shareholders
BackShareholdersView
- Stock & Share: shareholders' mag
- Become a shareholder
-
Follow the Air Liquide share
BackFollow the Air Liquide shareView
-
Follow the Air Liquide share
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Factsheets
BackFactsheetsView
- Understanding the stock market
- Stock orders
- Shareholding options
- Registering shares
- Loyalty bonus
- Personal online Account
- Capital gains
- Free share attribution
- Dividend
- Taxation
- Passing on shares
-
Factsheets
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Shareholders' Communication Committee
- Annual General Meeting
- Agenda
-
Media library
BackMedia libraryView
-
Media library
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Contact us
-
Shareholders
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Investors
BackInvestorsView
- Agenda
- Documents & Presentations
- Vara consensus
-
Investing in Air Liquide
BackInvesting in Air LiquideView
-
Investing in Air Liquide
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Credit investor
BackCredit investorView
-
Credit investor
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Governance
BackGovernanceView
- Corporate officers remuneration and regulated commitments
- Board committees
- Capital and articles of association, Internal Regulations, disclosure of share buy-back transactions
-
Governance
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
- Regulated information
- Contact us
-
Investors
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Media
-
Careers
BackCareersView
- Job offers
- I choose Air Liquide
-
Careers at Air Liquide
BackCareers at Air LiquideView
-
Careers at Air Liquide
- Find our job offers
- Spontaneous application
-
You at Air Liquide
BackYou at Air LiquideView
-
You at Air Liquide
- Find our job offers
- Spontaneous application
- Students
-
Graduates
BackGraduatesView
-
Graduates
- Find our job offers
- Spontaneous application
Healthcare: Air Liquide reinforces its presence in Europe with the acquisition of Medidis in the Netherlands
Air Liquide is pursuing the development of its Healthcare business in Europe with the acquisition of Medidis, a major player in the Netherlands for the treatment of respiratory diseases at home and the production and supply of medical oxygen. With this acquisition, Air Liquide, leader in home healthcare in Europe and present in the home healthcare market in the Netherlands for more than 20 years, strengthens its position in a growing market.
Medidis is a nationwide player that provides home healthcare support for patients suffering from respiratory failure and sleep apnea. Medidis supplies medical oxygen to patients being treated at home as well as those receiving care in assisted living facilities and to healthcare professionals who work outside the hospital setting. It also operates a medical oxygen production facility.
Present for more than 25 years in the Dutch market, Medidis employs more than 70 people and generated revenue of approximately 11 million euros in 2017. This acquisition both reinforces and diversifies Air Liquide’s existing healthcare offering and allows the Group to directly serve more than 26,000 additional patients in this country. Air Liquide will work with the existing teams to pursue the development of these businesses.
Already present in the Netherlands, Air Liquide will be able to leverage the complementarity of Medidis in both geographic and therapeutic terms. Concerning home healthcare, this acquisition will reinforce the Group’s position in the support of patients who suffer from respiratory failure. Moreover, it will increase its customer base with healthcare professionals who work outside the hospital (such as medical homes or ambulances). Air Liquide will also benefit from Medidis' established relationships with doctors, hospitals, and insurers in new regions and from an increased production capacity, which will allow the Group to further develop healthcare activities in the Netherlands.
François Jackow, member of the Air Liquide Executive Committee, supervising Healthcare activities stated:
“This acquisition gives Air Liquide an added dimension in the Dutch market. We are delighted to welcome the Medidis teams, recognized for their expertise in the treatment of respiratory diseases and their knowledge of the Dutch market, both at home and the growing market for the supply of medical oxygen outside the hospital. Air Liquide thus continues its momentum in terms of strengthening its positions in Europe, which is key to our strategy of developing the Healthcare business.”
Supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients. In 2018, it served over 15,000 hospitals and clinics and more than 1.6 million patients at home throughout the world. The Group’s Healthcare business reached €3,486 million in revenues in 2018, with the support of its 16,500 employees.
Air Liquide, European leader in home healthcare, provides home healthcare services in compliance with medical prescription for patients suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary Disease), sleep apnea and diabetes. These home healthcare services are being developed in addition to hospital care, enabling patients to enjoy better quality of life and local authorities to reduce costs. Home healthcare represents 45% of Air Liquide's revenue in Healthcare in 2018.
Download the pdf
© Air Liquide 2019